KR102526197B9 - Cotl1 composition for diagnosis preventing or treating bone diseases comprising cotl1 - Google Patents

Cotl1 composition for diagnosis preventing or treating bone diseases comprising cotl1

Info

Publication number
KR102526197B9
KR102526197B9 KR1020200155080A KR20200155080A KR102526197B9 KR 102526197 B9 KR102526197 B9 KR 102526197B9 KR 1020200155080 A KR1020200155080 A KR 1020200155080A KR 20200155080 A KR20200155080 A KR 20200155080A KR 102526197 B9 KR102526197 B9 KR 102526197B9
Authority
KR
South Korea
Prior art keywords
cotl1
composition
bone diseases
treating bone
diagnosis
Prior art date
Application number
KR1020200155080A
Other languages
Korean (ko)
Other versions
KR20210061289A (en
KR102526197B1 (en
Inventor
정선용
박은국
Original Assignee
아주대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아주대학교산학협력단 filed Critical 아주대학교산학협력단
Priority to US17/777,460 priority Critical patent/US20220403030A1/en
Priority to PCT/KR2020/016333 priority patent/WO2021101259A1/en
Publication of KR20210061289A publication Critical patent/KR20210061289A/en
Application granted granted Critical
Publication of KR102526197B1 publication Critical patent/KR102526197B1/en
Publication of KR102526197B9 publication Critical patent/KR102526197B9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020200155080A 2019-11-19 2020-11-19 Composition for diagnosis, preventing or treating bone diseases comprising cotl1 KR102526197B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US17/777,460 US20220403030A1 (en) 2019-11-19 2020-11-19 Composition, comprising cotl1 as active ingredient, for diagnosis of bone disease or obesity
PCT/KR2020/016333 WO2021101259A1 (en) 2019-11-19 2020-11-19 Composition, comprising cotl1 as active ingredient, for diagnosis of bone disease or obesity

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20190149077 2019-11-19
KR1020190149077 2019-11-19

Publications (3)

Publication Number Publication Date
KR20210061289A KR20210061289A (en) 2021-05-27
KR102526197B1 KR102526197B1 (en) 2023-04-27
KR102526197B9 true KR102526197B9 (en) 2023-11-13

Family

ID=76135856

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020200155080A KR102526197B1 (en) 2019-11-19 2020-11-19 Composition for diagnosis, preventing or treating bone diseases comprising cotl1

Country Status (1)

Country Link
KR (1) KR102526197B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220153830A (en) 2021-05-12 2022-11-21 주식회사 엘지에너지솔루션 Test connector for inspecting a connector with pins pushed back

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014204274A1 (en) 2013-06-21 2014-12-24 가톨릭대학교 산학협력단 Biomarker for rheumatoid arthritis diagnosis or activity evaluation
KR20160048442A (en) 2014-10-24 2016-05-04 가톨릭대학교 산학협력단 Biomarkers related to rheumatoid arthritis
CN110066866B (en) * 2019-01-17 2021-12-07 浙江大学 Biomarkers of osteoarthritis fourth subtype and uses

Also Published As

Publication number Publication date
KR20210061289A (en) 2021-05-27
KR102526197B1 (en) 2023-04-27

Similar Documents

Publication Publication Date Title
IL285782A (en) Compounds, compositions, and methods for the treatment of disease
IL275754A (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
ZA202007055B (en) Compositions for the treatment of skin conditions
ZA202006610B (en) Compositions for the treatment of skin conditions
SG11202012070YA (en) Methods and compositions for preventing or treating tissue calcification
IL287796A (en) Compositions and methods for the treatment of atpase-mediated diseases
EP4000609A4 (en) Pharmaceutical composition for preventing or treating bone diseases
EP3922264A4 (en) Pharmaceutical composition for preventing, ameliorating or treating skin disease
IL288793A (en) Compounds for treating respiratory disease
KR102526197B9 (en) Cotl1 composition for diagnosis preventing or treating bone diseases comprising cotl1
EP3927375A4 (en) Compositions for disease treatment
PL3810128T3 (en) Compositions for treating and/or preventing protein-aggregation diseases
SG11202007082PA (en) Composition used for therapeutic treatment of skin disease
IL291351A (en) Compositions for the treatment of solid tumors
ZA202107235B (en) Compositions and methods for treating ocular disease
EP3925623A4 (en) Medicinal composition for preventing or treating bone diseases
KR102090101B9 (en) Oral composition for preventation or treatment of oral disease
IL280589A (en) Compositions for the treatment of graft versus host disease
KR102276379B9 (en) IF1 ATPase inhibitory factor 1 Composition for Preventing or Treating Bone Diseases Comprising IF1
EP4052694A4 (en) Eye drop composition for preventing or treating eye disease
EP3936124A4 (en) Pharmaceutical composition for preventing or treating neurological diseases
GB201908076D0 (en) Skin treatment composition
SG11202011848RA (en) Medical implant
KR102316727B9 (en) Pharmaceutical composition for preventing or treating atopic diseases
EP3838272A4 (en) Composition for prevention or treatment of neurodegenerative disease

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
G170 Re-publication after modification of scope of protection [patent]